Kerala girl loses eyesight, doctor, hospital asked to pay Rs 10 lakh compensation
The first standard student who showed signs of squint on her left eye, was taken to the Kollam-based hospital on March 20, 2003. The ophthalmologist there, after conducting a fundoscopy and refraction test on the same day and on March 24, advised her to use a rubber cover over the right eye for at least four hours a day. She was asked to come for review after six months.
During the review in September, the doctor informed the parents that her left eye's vision was lost.
The parents then took her to the Aravind Eye Hospital, Tirunelveli, where a CT scan of the brain revealed an enlarged tumour in her brain. She was then referred to the Sree Chitra Thirunal Institute for Medical Sciences and Technology (SCTIMST) where she underwent a left pterional craniotomy and tumour decompression. After the operation, the minor girl lost her right eye's vision as well.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
2 hours ago
- Hans India
ICATT is Proposing to Launch ‘Flying ICU' Air Ambulance to Fast-Track Trauma Care in Andhra Pradesh
ICATT, a Bengaluru-based air ambulance services company, has initiated discussions with the Andhra Pradesh state government to launch its cutting-edge and integrated Helicopter Emergency Medical Services (HEMS) to fast-track trauma care services in the state. ICATT deploys 'Flying ICUs' — helicopters and aircraft equipped with advanced ICU infrastructure, surgical tools, and a trained aero-medical team. These airborne units are capable of delivering critical care at the site of trauma, particularly along highways, rural belts, and semi-urban areas, within the crucial golden hour, significantly improving the chances of survival for accident victims. ICATT's air ambulance service, an India-specific adaptation of the UK's Helicopter Emergency Medical Services (HEMS) model, has been successfully operating the government-funded PM Shri Air Ambulance Seva in Madhya Pradesh for the past year. The system functions in close coordination with the National Health Mission's first responders and the State Administration, covering all 55 districts using a dedicated helicopter and fixed-wing air ambulance. Under this model, trauma victims and critically ill patients are airlifted free of cost, ensuring timely access to lifesaving care. Building on this success, ICATT is now set to replicate the same Public-Private Partnership (PPP) model in other states, bringing together key departments including fire services, police, and first-responder ambulance units to form a seamless emergency medical network. Prior to the Madhya Pradesh contract, ICATT had successfully conducted Aero-Medical Rescue operations in the deep jungles of Southern Chhattisgarh based at Jagdalpur and saving lives of the CRPF jawans fighting the Naxalites. In their comments, Dr. Rahul Singh Sardar and Dr. Shalini Nalwad, Founding Directors of ICATT Air Ambulance Service, said, 'HEMS represents a significant disruption in the emergency care landscape. In countries like the USA, UK, and across Europe, air ambulance teams are a standard part of trauma care, a highly evolved and efficient system that saves countless lives. We are bringing that same global standard of care to India, where such services are not just desirable but essential. With access to advanced medical facilities still limited in many parts of the country, we believe the introduction of HEMS can play a critical role in reducing road accident fatalities and improving emergency response outcomes.' They pointed out that road accident fatalities in India rose to approximately 1.80 lakh in 2024, accounting for over 11% of global road deaths. Although India is a signatory to the Brasilia Declaration, which aims to reduce road accidents and fatalities by 50%, achieving this goal will require the integration of advanced systems like HEMS. The duo gained experience with the UK's HEMS model during their training and practice in Pre-Hospital Trauma Care in England between 2004 and 2015. They returned and established ICATT Air Ambulance Service in 2017 with a singular mission of reducing the death rate among trauma victims in the country, and now they are the largest Air Ambulance Service of India. 'However, this vision can only be realised through strong collaboration with government bodies and institutions,' they emphasized. 'Saving trauma victims requires an integrated approach and a well-coordinated response between first responders and air ambulance services.' ICATT's team of flying doctors and paramedics is trained through a specialized programme called FAM (Fellowship in Aeromedical Sciences), jointly developed by ICATT and its British training partners, designed specifically for Indian conditions, the programme brings together global experts from the UK and Australia to equip medical professionals with advanced skills in aeromedical emergency care. These professionals, referred to as 'Aero-medical commandos', are trained to perform life-saving interventions in the most challenging and resource-constrained environments, ensuring critical care reaches even the most inaccessible locations. The company has conducted successful aero-medical drills in several Indian cities, including Raipur and Chennai. In Andhra Pradesh, it is collaborating with the Government and leading Tertiary hospitals to showcase its integrated HEMS (Helicopter Emergency Medical Services) model. These drills simulate real-life trauma scenarios, followed by an advanced aero-medical rescue operation. The coordinated response involves the police, fire department, first responder ambulance, and a fully equipped helicopter staffed by highly trained medical professionals. The helicopter is dispatched to the accident site, where the patient is stabilised on the ground through life-saving interventions such as field anaesthesia and critical care procedures. The patient is then airlifted to the nearest hospital for further treatment. From the time of the accident to air evacuation, the entire process, including on-site stabilisation, is completed within 30 minutes, demonstrating the efficiency and impact of a well-orchestrated emergency care system.
Hindustan Times
3 hours ago
- Hindustan Times
Walmart hand soap recall: Here's why DermaRite products were recalled. Full list
DermaRite Industries LLC, a New Jersey-based company that manufactures healthcare products, has voluntarily recalled several commodities it had distributed, including hand soap, cleanser, and analgesic, due to 'microbial contamination', the Food and Drug Administration (FDA) informed. According to the company's official announcement, the contaminated products can cause 'life-threatening' health issues, as per People. Life-threatening sepsis risk sparks urgent recall of hand soap nationwide (Unsplash) The FDA posted DermaRite Industries LLC's announcement dated August 8, 2025, on their website. According to the announcement, DermaRite has asked its distributors and customers 'to immediately examine available inventory and destroy all affected products.' Per the company's announcement, the products it has recalled contain Burkholderia cepacia, which can cause 'serious and life-threatening infections." Infection caused by these contaminated products can 'spread into the bloodstream' of immunocompromised individuals, 'leading to life-threatening sepsis', DermaRite announced. Also read: FDA recalls butter across US: What Class II warning means, which product has been recalled 'To date, DermaRite has not received any reports of adverse events related to this recall,' the company added. What is Burkholderia cepacia? Burkholderia cepacia is a group of bacteria that can easily infect individuals with weakened immune systems or chronic lung diseases like cystic fibrosis, according to Centers for Disease Control (CDC). The germs, which are found in water and soil, can spread from person to person. Due to its antimicrobial resistance, Burkholderia cepacia can be pretty difficult to treat. Early symptoms of infections caused by Burkholderia cepacia include fever and fatigue. FAQs What products has DermaRite Industries LLC recalled? DermaRite Industries LLC has recalled the following products: DermaKleen, an antiseptic lotion soap; DermaSarra, an analgesic; KleenFoam, an antimicrobial foam soap; and PeriGiene, an antiseptic cleanser. Why did DermaRite Industries LLC recall its products? DermaRite Industries LLC recalled its products because they can cause 'life-threatening" health complications due to bacterial contamination. Does the FDA endorse DermaRite Industries LLC? No, the FDA does not endorse DermaRite Industries LLC like that. When a company announces a recall, it voluntarily shares the information on its website for public service. What is Burkholderia cepacia? Burkholderia cepacia is a group of bacteria that infects individuals with weakened immune systems or chronic lung diseases.
Mint
6 hours ago
- Mint
Biogen Sees Potential in Combining Alzheimer's and Obesity Drugs
(Bloomberg) -- If Novo Nordisk A/S's wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer's disease, Biogen Inc.'s Chief Executive Officer Chris Viehbacher doesn't see it as a roadblock for his company's medication. Rather, he sees it as an opportunity to potentially combine drugs and create a more potent therapy. 'As we look out over the next five years, we're probably going to see a treatment much like any other complex disease,' he said in an interview with Bloomberg News, meaning there will be 'different mechanisms of action that you need.' It's not uncommon for drugmakers to study combinations of treatments when two seem to work for the same condition, in hope of boosting the benefit. Viehbacher said if Novo's study works, Biogen 'might' do trials looking at the two drugs in combination but cautioned the timeline might not make sense given Alzheimer's studies take years to complete. Biogen's looking to the growth of its Alzheimer's drug Leqembi to offset the decline of its multiple sclerosis franchise, which is facing competition from cheaper generic drugs. Biogen's new Alzheimer's drug is already facing competition from Eli Lilly & Co.'s Alzheimer's drug, which was approved in the US last year and has since captured around 30% of the market, according to analysts. Other companies are also circling. Novo is carrying out clinical trials to assess whether the main ingredient in diabetes drug Ozempic and weight-loss shot Wegovy might help people with early Alzheimer's disease. Research suggests that the weight-loss drug could slow Alzheimer's progression by impacting inflammation and vascular health. Results of Novo's late-stage trial are expected later this year. Viehbacher noted that being overweight is a risk factor for Alzheimer's. He cautioned the Novo study 'is a fairly risky proposition,' adding that 'most of the experts we're talking to are not convinced that it will work.' 'It's logical if you have a weight-loss drug that you can see some benefit, but it's actually pretty hard to move the needle on the cognitive side,' Viehbacher added. Alzheimer's drug development has been riddled with failures, even when drugs looked promising in early studies. Leqembi is a partnership between Cambridge, Massachusetts-based Biogen and Japanese drugmaker Eisai Co. Biogen makes the active ingredient for Leqembi in Switzerland. The company then ships it to North Carolina, where it gets made into a product. President Donald Trump recently put a 39% tariff on imports from Switzerland. It's unclear whether this would impact Biogen's drug. Still, Viehbacher said the company has the ability to start producing the substance used to make Leqembi in North Carolina for the US market, while continuing to make it in Switzerland for outside the US. He said the company always intended to use its North Carolina facilities to make Leqembi and the potential move was not a direct response to Trump's tariff threats. Last month, Biogen announced it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park. More stories like this are available on
